The Prison Rape Prevention Act of 2025 mandates that the Bureau of Prisons house and transport inmates based on biological sex and prohibits the use of federal funds for gender-related medical treatments.
Nancy Mace
Representative
SC-1
The Prison Rape Prevention Act of 2025 mandates that the Bureau of Prisons house and transport inmates exclusively according to their biological sex. Additionally, the bill prohibits the Bureau from providing or funding gender-related medical treatments for prisoners.
This bill fundamentally reshapes how the Federal Bureau of Prisons (BOP) manages the housing, transportation, and healthcare of incarcerated individuals. Under Section 2, the BOP would be required to house and transport prisoners strictly with others of the same 'biological sex,' a term the bill defines based on a person’s reproductive system (specifically the capacity to produce eggs or sperm). Beyond physical placement, the legislation enacts a total ban on the federal government providing or funding any 'gender-related medical treatment,' ranging from hormone therapies to a wide array of surgical procedures.
The bill creates a rigid standard for prison logistics. By amending Section 3621 of title 18, it removes administrative flexibility, requiring that every prisoner be grouped solely by their biological sex during their entire term of imprisonment and while in transit. For a transgender woman who has lived as a female for years, this means she would be housed in a men’s facility. The bill defines 'gender' as a synonym for 'sex' and explicitly states it does not include gender identity or expression. This shift moves away from current case-by-case safety assessments, potentially placing vulnerable individuals in environments where their physical safety could be compromised by the general population.
Perhaps the most significant change for daily prison operations is the comprehensive list of prohibited medical treatments. The bill specifically names procedures like mastectomies, hormone doses (estrogen or testosterone), and puberty blockers as off-limits. There are very narrow exceptions for individuals with 'irresolvably ambiguous' biological sex characteristics or those suffering from an injury caused by a previous gender-related treatment. For a healthcare provider working within the BOP, this means their professional medical judgment regarding a patient’s gender dysphoria is effectively overruled by a blanket statutory ban. This could lead to a situation where a prisoner mid-transition is abruptly cut off from long-term medication, which often carries significant physical and psychological health risks.
The bill’s definitions are high-stakes. By defining 'male' and 'female' through the lens of reproductive potential—even if those systems are currently inactive—it creates a legal framework that leaves little room for nuance. Furthermore, the Director of the BOP is given the authority to identify 'any other treatment' to add to the prohibited list, creating a moving target for what constitutes allowable healthcare. While the bill’s title suggests a focus on preventing sexual assault, the practical implementation focuses heavily on the biological classification of the body, which may create new safety challenges for guards and inmates alike as they navigate a system that no longer recognizes gender identity in its housing or medical protocols.